Literature DB >> 26206526

Prediction of Areal Bone Mineral Density and Bone Mineral Content in Children and Adolescents Living With HIV Based on Anthropometric Variables.

Luiz Rodrigo Augustemak de Lima1, Rodrigo de Rosso Krug2, Rosane Carla Rosendo da Silva3, Aroldo Prohmann de Carvalho4, David Alejandro González-Chica5, Isabela de Carlos Back6, Edio Luiz Petroski3.   

Abstract

Children and adolescents living with HIV have low bone mass for age. There are reliable and accurate methods for evaluation of bone mass, however, alternative methods are necessary, especially, for application in limited-resource scenarios. Anthropometry is a noninvasive and low cost method that can predict bone mass in healthy youths. The aim of the study was to develop predictive equations for bone mineral content and bone mineral density in children and adolescents living with HIV based on anthropometric variables. Forty-eight children and adolescents of both sexes (24 females) from 7 to 17 years, living in greater Florianopolis area, Santa Catarina, Brazil, who were under clinical follow-up at "Hospital Infantil Joana de Gusmão", participated in the study. Dual-energy X-ray absorptiometry was used to evaluate whole-body bone mineral content (BMC) and areal bone mineral density (aBMD). Height, body weight, bone diameters, arm circumference, and triceps skinfold were measured and the body mass index and arm muscle area were calculated. Multiple regression models were fitted to predict BMC and aBMD, using backward selection (p ≥ 0.05). Two predictive models with high R2 values (84%-94%) were developed. Model 1 to estimate aBMD [Y = -0.1450124 + (height × 0.0033807) + (age × 0.0146381) + (body mass index × 0.0158838) + (skin color × 0.0421068)], and model 2 to estimate BMC [Y = 1095.1 + (body weight × 45.66973) + (age × 31.36516) + (arm circumference × -53.27204) + (femoral diameter × -9.594018)].The predictive models using anthropometry provided reliable estimates and can be useful to monitor aBMD and BMC in children and adolescents living with human immunodeficiency virus where limited resources are available.
Copyright © 2016 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acquired immunodeficiency syndrome; HIV; anthropometry; bone density; osteoporosis

Mesh:

Year:  2015        PMID: 26206526     DOI: 10.1016/j.jocd.2015.06.001

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.617


  5 in total

Review 1.  Noncommunicable diseases in adolescents with perinatally acquired HIV-1 infection in high-income and low-income settings.

Authors:  Steve Innes; Kunjal Patel
Journal:  Curr Opin HIV AIDS       Date:  2018-05       Impact factor: 4.283

Review 2.  Bone health in HIV-infected children and adolescents.

Authors:  Allison R Eckard; Stefano Mora
Journal:  Curr Opin HIV AIDS       Date:  2016-05       Impact factor: 4.283

3.  Impact of HIV-1 Infection and Antiretroviral Therapy on Bone Homeostasis and Mineral Density in Vertically Infected Patients.

Authors:  D Donà; E Mozzo; D Luise; R Lundin; A Padoan; O Rampon; C Giaquinto
Journal:  J Osteoporos       Date:  2019-01-01

4.  Bone Mineral Content Estimation in People Living with HIV: Prediction and Validation of Sex-Specific Anthropometric Models.

Authors:  Igor Massari Correia; Anderson Marliere Navarro; Jéssica Fernanda Corrêa Cordeiro; Euripedes Barsanulfo Gonçalves Gomide; Lisa Fernanda Mazzonetto; Alcivandro de Sousa Oliveira; Emerson Sebastião; Bruno Augusto Aguilar; Denise de Andrade; Dalmo Roberto Lopes Machado; André Pereira Dos Santos
Journal:  Int J Environ Res Public Health       Date:  2022-09-28       Impact factor: 4.614

5.  Are traditional body fat equations and anthropometry valid to estimate body fat in children and adolescents living with HIV?

Authors:  Luiz Rodrigo Augustemak de Lima; Priscila Custódio Martins; Carlos Alencar Souza Alves Junior; João Antônio Chula de Castro; Diego Augusto Santos Silva; Edio Luiz Petroski
Journal:  Braz J Infect Dis       Date:  2017-05-19       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.